siRNA Transfection and EMSA Analyses on Freshly Isolated Human Villous Cytotrophoblasts.
Human primary villous cytotrophoblasts are a very useful source of primary cells to study placental functions and regulatory mechanisms, and to comprehend diseases related to pregnancy. In this protocol, human primary villous cytotrophoblasts freshly isolated from placentas through a standard DNase/trypsin protocol are microporated with small interfering RNA (siRNA). This approach provided greater efficiency for siRNA transfection when compared to a lipofection-based method. Transfected cells can subsequently be analyzed by standard Western blot within a time frame of 3-4 days post-transfection. In addition, using cultured primary villous cytotrophoblasts, Electrophoretic Mobility Shift Assay (EMSA) analysis was optimized and performed on extracts from days 1 to 4. The use of these cultured primary cells and the protocol described allow for an evaluation of the implication of specific genes and transcription factors in the process of villous cytotrophoblast differentiation into a syncytiotrophoblast-like cell layer. However, the limited time span allowable in culture precludes the use of methods requiring more time, such as generation of a stable cell population. Therefore testing of this cell population requires highly optimized gene transfer protocols.
Department of Biological Sciences, University of Quebec in Montreal.
Adjimon Gatien
AG
Lokossou
Department of Pharmacology and Therapeutics, McGill University.
Chirine
C
Toufaily
Department of Clinical Sciences, University of Montreal.
Amandine
A
Vargas
Department of Biological Sciences, University of Quebec in Montreal; barbeau.benoit@uqam.ca.
Benoit
B
Barbeau
D002454:Cell Differentiation; D002478:Cells, Cultured; D024202:Electrophoretic Mobility Shift Assay; D005260:Female; D006801:Humans; D010920:Placenta; D011247:Pregnancy; D034741:RNA, Small Interfering; D014157:Transcription Factors; D014162:Transfection; D014327:Trophoblasts
D034741:RNA, Small Interfering; D014157:Transcription Factors
Hypertension. 2008 Apr;51(4):970-5
18259009
Anal Biochem. 1985 Oct;150(1):76-85
3843705
Methods Mol Med. 2006;121:203-17
16251745
J Mol Biol. 2009 Sep 18;392(2):301-18
19616006
J Physiol. 2009 Jan 15;587(1):61-72
19015196
Placenta. 1997 Sep;18(7):577-85
9290154
Placenta. 2010 Mar;31 Suppl:S75-81
20042237
J Control Release. 2007 Nov 20;123(3):184-94
17913276
Methods Mol Biol. 2009;550:73-87
19495697
Placenta. 2009 Feb;30(2):124-9
19012963
PLoS One. 2015 Mar 17;10(3):e0121468
25781974
Anal Biochem. 1976 May 7;72:248-54
942051
Biochem J. 2013 Oct 15;455(2):133-47
24070422
Placenta. 2002 Feb-Mar;23(2-3):175-83
11945084
Proc Natl Acad Sci U S A. 1987 Nov;84(21):7413-7
2823261
Placenta. 2000 Sep;21(7):733-41
10985978